시장보고서

상품코드

1807409

세계의 항생제 시장 : 규모, 점유율 및 동향, 업계 분석(약제 클래스별, 유형별, 작용 기전별, 지역별), 예측(2025-2034년)

Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class, By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034

발행일: 2025년 08월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 항생제 시장 규모는 2034년까지 758억 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

항생제는 유해한 박테리아의 증식을 억제하거나 제거하도록 설계된 치료제이며, 의료 환경 전반에서 박테리아 감염의 관리에 중심적인 역할을 합니다. 항생제 시장을 견인하고 있는 것은 항균제 내성에 대한 우려가 높아지고 차세대 항생제 개발에 다시 관심이 쏠리고 있습니다. 제약회사와 연구기관은 기존 항생제가 진화하는 세균주에 대한 효능을 잃고 있기 때문에 신규 화합물과 혁신적인 치료 전략의 발견을 위한 노력을 강화하고 있습니다. 이 변화는 표적 요법과 정밀의료에 대한 관심 증가와 함께 시장 전망을 재정의하고 있습니다.

항생제의 발견과 개발에 있어서 인공지능과 머신러닝 플랫폼의 통합이 진행되고 있는 것도 시장의 성장에 기여하고 있습니다. 이러한 기술은 유망한 약물 후보의 식별을 가속화하고, 임상시험 디자인을 최적화하고, 내성 패턴의 예측 모델링을 강화합니다. 디지털 혁신의 적용은 항생제 개발과 관련된 시간과 비용을 줄이고 성공 가능성을 높입니다. 그 결과 기술 통합은 연구 파이프라인을 재구성하고 항생제 치료의 미래 전망을 확대하는 혁신적인 힘으로 부상하고 있습니다.

항생제 시장 : 분석 개요

유형별로는 제네릭 항생제 분야가 2024년에 81.48%의 매출 점유율을 차지했으며, 저렴한 가격, 폭넓은 입수가능성, 주요 브랜드 의약품의 특허실효가 그 요인이 되고 있습니다.

작용 기전별로는 RNA 합성 억제제 분야가 세균 경로를 표적으로 하고 내성균에 대처하는 정밀도가 높아 예측 기간 동안 가장 빠른 성장을 기록할 것으로 예측됩니다.

북미는 2024년에 항생제 세계 시장의 39.36%를 차지했으며, 엄격한 항생제 스튜어드십, 감시 시스템, 첨단 치료 혁신에 지원되고 있습니다.

아시아태평양 시장은 인구 증가, 의료 인프라 정비, 감염에 대한 의식 증가에 힘입어 예측 기간 동안 크게 성장할 전망입니다.

세계의 주요 시장 기업으로는 Astellas Pharma Inc., AstraZeneca, Cipla, Fresenius Kabi AG, GSK plc, Hetero Healthcare Limited, Lupin Pharmaceuticals, Inc, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd 등이 있습니다.

시장 현황
항생제 시장 역학
- 성장 촉진요인과 기회
  - 고령화 인구 증가
  - 연구개발의 진보
- 억제요인과 과제
  - 수익성이 낮아 경제적 및 재정적 과제
  - 여론과 프라이버시에 관한 판례
PESTLE 분석
항생제 시장 동향
밸류체인 분석

제5장 항생제 시장 : 약제 클래스별

주요 분석 결과
소개
세팔로스포린
페니실린
플루오로퀴놀론
마크롤라이드
카바페넴
아미노글리코시드
술폰아미드
7-ACA
기타

제6장 항생제 시장 : 유형별

주요 분석 결과
소개
브랜드 항생제
제네릭 항생제

제7장 항생제 시장 : 작용 기전별

주요 분석 결과
소개
세포벽 합성 억제제
단백질 합성 억제제
DNA 합성 억제제
RNA 합성 억제제
미콜산 억제제

제8장 항생제 시장 : 지역별

주요 분석 결과
소개
- 항생제 시장 분석 : 지역별(2020-2034년)
북미
- 북미 : 약제 클래스별, 지역별(2020-2034년)
- 북미 : 유형별, 지역별(2020-2034년)
- 북미 : 작용 기전별, 지역별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 약제 클래스별, 지역별(2020-2034년)
- 유럽 : 유형별, 지역별（2020-2034년）
- 유럽 : 작용 기전별, 지역별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 약제 클래스별, 지역별(2020-2034년)
- 아시아태평양 : 유형별, 지역별(2020-2034년)
- 아시아태평양 : 작용 기전별, 지역별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 약제 클래스별, 지역별(2020-2034년)
- 중동 및 아프리카 : 유형별, 지역별（2020-2034년）
- 중동 및 아프리카 : 작용 기전별, 지역별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 약제 클래스별, 지역별, 2020-2034년
- 라틴아메리카 : 유형별, 지역별(2020-2034년)
- 라틴아메리카 : 작용 기전별, 지역별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
제휴/협업/합의/공개

제10장 기업 프로파일

Astellas Pharma Inc.
AstraZeneca
Cipla
Fresenius Kabi AG
GSK plc
Hetero Healthcare Limited
Lupin Pharmaceuticals, Inc
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.

JHS 25.09.22

The antibiotics market size is expected to reach USD 75.80 billion by 2034, according to a new study by Polaris Market Research. The report "Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibiotics are therapeutic agents designed to inhibit the growth of or eliminate harmful bacteria, playing a central role in managing bacterial infections across healthcare environment. The antibiotics market is driven due to the escalating concern over antimicrobial resistance, which is prompting renewed interest in the development of next-generation antibiotics. Pharmaceutical companies and research institutions are intensifying their efforts to discover novel compounds and innovative treatment strategies as traditional antibiotics lose efficacy against evolving bacterial strains. This shift is redefining the market landscape, with a growing focus on targeted therapies and precision medicine.

The increasing integration of artificial intelligence and machine learning platforms in antibiotic discovery and development contributes to the market's growth. These technologies are accelerating the identification of promising drug candidates, optimizing clinical trial design, and enhancing predictive modeling for resistance patterns. The application of digital innovation reduces the time and cost associated with antibiotic development and increases the likelihood of successful outcomes. As a result, technological integration is emerging as a transformative force in reshaping the research pipeline and expanding the future scope of antibiotic therapies.

Antibiotics Market Report Highlights

In terms of type, the generic antibiotics segment held an 81.48% revenue share in 2024, fueled by affordability, broad availability, and patent expirations of major branded drugs.

Based on action mechanism, the RNA synthesis inhibitors segment is anticipated to register the fastest growth during the forecast period, driven by their precision in targeting bacterial pathways and addressing resistance.

North America captured 39.36% of the global antibiotics market in 2024, supported by stringent antibiotic stewardship, surveillance systems, and advanced treatment innovations.

The Asia Pacific market is poised for significant growth during the forecast period, propelled by population growth, improved healthcare infrastructure, and rising infectious disease awareness.

A few global key market players include Astellas Pharma Inc.; AstraZeneca; Cipla; Fresenius Kabi AG; GSK plc; Hetero Healthcare Limited; Lupin Pharmaceuticals, Inc; Merck & Co., Inc.; Pfizer Inc.; and Teva Pharmaceutical Industries Ltd..

Polaris Market Research has segmented the antibiotics market report on the basis of drug class, type, action mechanism, and region:

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Cephalosporin

Penicillin

Fluoroquinolone

Macrolides

Carbapenems

Aminoglycosides

Sulfonamides

7-ACA

Others

By Type Outlook (Revenue, USD Billion, 2020-2034)

Branded Antibiotics

Generic Antibiotics

By Action Mechanism Outlook (Revenue, USD Billion, 2020-2034)

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Mycolic Acid Inhibitors

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Antibiotics Market Insights

4.1. Antibiotics Market - Market Snapshot
4.2. Antibiotics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Geriatric Population
  - 4.2.1.2. Advancements in Research and Development
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Economic and Financial Challenge due to Low Profitability
- 4.2.3. Public opinion and privacy legal precedents
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Antibiotics Market Trends
4.6. Value Chain Analysis

5. Antibiotics Market, By Drug Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Antibiotics Market, By Drug Class, 2020-2034 (USD Billion)
5.3. Cephalosporin
- 5.3.1. Antibiotics Market, by Cephalosporin,2020-2034 (USD Billion)
5.4. Penicillin
- 5.4.1. Antibiotics Market, by Penicillin,2020-2034 (USD Billion)
5.5. Fluoroquinolone
- 5.5.1. Antibiotics Market, by Fluoroquinolone,2020-2034 (USD Billion)
5.6. Macrolides
- 5.6.1. Antibiotics Market, by Macrolides,2020-2034 (USD Billion)
5.7. Carbapenems
- 5.7.1. Antibiotics Market, by Carbapenems,2020-2034 (USD Billion)
5.8. Aminoglycosides
- 5.8.1. Antibiotics Market, by Aminoglycosides,2020-2034 (USD Billion)
5.9. Sulfonamides
- 5.9.1. Antibiotics Market, by Sulfonamides,2020-2034 (USD Billion)
5.10. 7-ACA
- 5.10.1. Antibiotics Market, by 7-ACA,2020-2034 (USD Billion)
5.11. Others
- 5.11.1. Antibiotics Market, by Others,2020-2034 (USD Billion)

6. Antibiotics Market, By Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Antibiotics Market, By Type, 2020-2034 (USD Billion)
6.3. Branded Antibiotics
- 6.3.1. Antibiotics Market, by Branded Antibiotics,2020-2034 (USD Billion)
6.4. Generic Antibiotics
- 6.4.1. Antibiotics Market, by Generic Antibiotics,2020-2034 (USD Billion)

7. Antibiotics Market, By Action Mechanism

7.1. Key Findings
7.2. Introduction
- 7.2.1. Antibiotics Market, By Action Mechanism, 2020-2034 (USD Billion)
7.3. Cell Wall Synthesis Inhibitors
- 7.3.1. Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020-2034 (USD Billion)
7.4. Protein Synthesis Inhibitors
- 7.4.1. Antibiotics Market, by Protein Synthesis Inhibitors,2020-2034 (USD Billion)
7.5. DNA Synthesis Inhibitors
- 7.5.1. Antibiotics Market, by DNA Synthesis Inhibitors,2020-2034 (USD Billion)
7.6. RNA Synthesis Inhibitors
- 7.6.1. Antibiotics Market, by RNA Synthesis Inhibitors,2020-2034 (USD Billion)
7.7. Mycolic Acid Inhibitors
- 7.7.1. Antibiotics Market, by Mycolic Acid Inhibitors,2020-2034 (USD Billion)

8. Antibiotics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Antibiotics Market Assessment, By Geography, by Region, 2020-2034 (USD Billion)
8.3. Antibiotics Market - North America
- 8.3.1. North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
- 8.3.2. North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
- 8.3.3. North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.3.4. Antibiotics Market - US
  - 8.3.4.1. US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.3.4.2. US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.3.4.3. US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.3.5. Antibiotics Market - Canada
  - 8.3.5.1. Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.4. Antibiotics Market - Europe
- 8.4.1. Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
- 8.4.2. Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
- 8.4.3. Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.4. Antibiotics Market - UK
  - 8.4.4.1. UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.5. Antibiotics Market - France
  - 8.4.5.1. France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.6. Antibiotics Market - Germany
  - 8.4.6.1. Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.7. Antibiotics Market - Italy
  - 8.4.7.1. Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.8. Antibiotics Market - Spain
  - 8.4.8.1. Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.9. Antibiotics Market - Netherlands
  - 8.4.9.1. Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.10. Antibiotics Market - Russia
  - 8.4.10.1. Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.4.11. Antibiotics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.5. Antibiotics Market - Asia Pacific
- 8.5.1. Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.4. Antibiotics Market - China
  - 8.5.4.1. China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.5. Antibiotics Market - India
  - 8.5.5.1. India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.6. Antibiotics Market - Malaysia
  - 8.5.6.1. Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.7. Antibiotics Market - Japan
  - 8.5.7.1. Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.8. Antibiotics Market - Indonesia
  - 8.5.8.1. Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.9. Antibiotics Market - South Korea
  - 8.5.9.1. South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.10. Antibiotics Market - Australia
  - 8.5.10.1. Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.5.11. Antibiotics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.6. Antibiotics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.6.4. Antibiotics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.6.5. Antibiotics Market - UAE
  - 8.6.5.1. UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.6.6. Antibiotics Market - Israel
  - 8.6.6.1. Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.6.7. Antibiotics Market - South Africa
  - 8.6.7.1. South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.6.8. Antibiotics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
8.7. Antibiotics Market - Latin America
- 8.7.1. Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.7.4. Antibiotics Market - Mexico
  - 8.7.4.1. Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.7.5. Antibiotics Market - Brazil
  - 8.7.5.1. Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.7.6. Antibiotics Market - Argentina
  - 8.7.6.1. Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
- 8.7.7. Antibiotics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Astellas Pharma Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AstraZeneca
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Cipla
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Fresenius Kabi AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. GSK plc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Hetero Healthcare Limited
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Lupin Pharmaceuticals, Inc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merck & Co., Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Pfizer Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Teva Pharmaceutical Industries Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development